MARKET

NRSNW

NRSNW

Neurosense Therapeutics Ltd
NASDAQ
0.0733
0.0000
0.00%
Closed 09:30 07/06 EDT
OPEN
--
PREV CLOSE
0.0733
HIGH
--
LOW
--
VOLUME
56
TURNOVER
--
52 WEEK HIGH
1.000
52 WEEK LOW
0.0600
MARKET CAP
--
P/E (TTM)
-0.1679
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NRSN last week (0629-0703)?
Weekly Report · 13h ago
Neurosense Therapeutics Ltd. (NRSN) Gets a Buy from Noble Financial
TipRanks · 4d ago
BUZZ-U.S. STOCKS ON THE MOVE-Regenxbio, Repay,  Natera, Fortune Brands
Reuters · 06/29 15:37
NeuroSense Hits Key TDP-43 Endpoint in Phase 2b ALS Trial, Advances Toward Phase 3
TipRanks · 06/29 13:57
BUZZ-NeuroSense rises as nerve disease drug shows promise in study
Reuters · 06/29 13:51
NeuroSense Says Phase 2b ALS Study Meets Primary Endpoint
NASDAQ · 06/29 13:49
NeuroSense says Phase 2b PARADIGM study of PrimeC in ALS met endpoint
TipRanks · 06/29 13:35
NeuroSense Therapeutics Announces Its Phase 2B PARADIGM Study Of PrimeC In Amyotrophic Lateral Sclerosis Has Met Its Primary Efficacy Endpoint
Benzinga · 06/29 13:32
More
About NRSNW
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease

Webull offers Neurosense Therapeutics Ltd stock information, including NASDAQ: NRSNW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRSNW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRSNW stock methods without spending real money on the virtual paper trading platform.